pI: 10.4401 |
Length (AA): 304 |
MW (Da): 31673 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Procyclic. | Siegel TN |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_127191)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G25630 | mediator of RNA polymerase II transcription subunit 36a |
Babesia bovis | BBOV_III008920 | fibrillarin, putative |
Brugia malayi | Bm1_55190 | Fibrillarin |
Candida albicans | CaO19.3138 | similar to human fibrillarin |
Candida albicans | CaO19.10650 | similar to human fibrillarin |
Caenorhabditis elegans | CELE_T01C3.7 | Protein FIB-1 |
Cryptosporidium hominis | Chro.80497 | fibrillarin |
Cryptosporidium parvum | cgd8_4330 | fibrillarin. RNA methylase |
Dictyostelium discoideum | DDB_G0269878 | rRNA 2'-O-methyltransferase |
Drosophila melanogaster | Dmel_CG9888 | Fibrillarin |
Echinococcus granulosus | EgrG_000801600 | rRNA 2' O methyltransferase fibrillarin |
Entamoeba histolytica | EHI_118840 | fibrillarin, putative |
Echinococcus multilocularis | EmuJ_000801600 | rRNA 2' O methyltransferase fibrillarin |
Giardia lamblia | GL50803_97219 | Fibrillarin-like pre-rRNA processing protein Narcisi et al |
Homo sapiens | ENSG00000105202 | fibrillarin |
Leishmania braziliensis | LbrM.35.3290 | fibrillarin |
Leishmania braziliensis | LbrM.19.0410 | fibrillarin, putative |
Leishmania donovani | LdBPK_363220.1 | fibrillarin |
Leishmania donovani | LdBPK_190090.1 | fibrillarin, putative |
Leishmania infantum | LinJ.36.3220 | fibrillarin |
Leishmania infantum | LinJ.19.0090 | fibrillarin, putative |
Leishmania major | LmjF.36.3070 | fibrillarin |
Leishmania major | LmjF.19.0100 | fibrillarin, putative |
Leishmania mexicana | LmxM.36.3070 | fibrillarin |
Leishmania mexicana | LmxM.19.0100 | fibrillarin, putative |
Loa Loa (eye worm) | LOAG_04840 | fibrillarin |
Mus musculus | ENSMUSG00000046865 | fibrillarin |
Mus musculus | 102643269 | rRNA 2'-O-methyltransferase fibrillarin-like |
Neospora caninum | NCLIV_055330 | Fibrillarin superfamily, related |
Plasmodium berghei | PBANKA_1035100 | rRNA 2'-O-methyltransferase fibrillarin, putative |
Plasmodium falciparum | PF3D7_1407100 | rRNA 2'-O-methyltransferase fibrillarin, putative |
Plasmodium knowlesi | PKNH_1351000 | rRNA 2'-O-methyltransferase fibrillarin, putative |
Plasmodium vivax | PVX_086075 | fibrillarin, putative |
Saccharomyces cerevisiae | YDL014W | rRNA methyltransferase NOP1 |
Schistosoma japonicum | Sjp_0009930 | rRNA 2'-O-methyltransferase fibrillarin 1, putative |
Schistosoma mansoni | Smp_044280.2 | fibrillarin |
Schistosoma mansoni | Smp_044280.1 | fibrillarin |
Schmidtea mediterranea | mk4.014323.00 | rRNA 2'-O-methyltransferase fibrillarin |
Schmidtea mediterranea | mk4.004042.00 | rRNA 2'-O-methyltransferase fibrillarin |
Schmidtea mediterranea | mk4.009129.00 | rRNA 2'-O-methyltransferase fibrillarin |
Schmidtea mediterranea | mk4.000957.12 | rRNA 2'-O-methyltransferase fibrillarin |
Trypanosoma brucei gambiense | Tbg972.10.17780 | fibrillarin, putative |
Trypanosoma brucei gambiense | Tbg972.10.9180 | fibrillarin, putative |
Trypanosoma brucei gambiense | Tbg972.10.17910 | fibrillarin, putative |
Trypanosoma brucei | Tb927.10.14750 | fibrillarin, putative |
Trypanosoma brucei | Tb927.10.7500 | fibrillarin |
Trypanosoma brucei | Tb927.10.14630 | fibrillarin, putative |
Trypanosoma congolense | TcIL3000_10_6460 | fibrillarin, putative |
Trypanosoma cruzi | TcCLB.510105.50 | fibrillarin, putative |
Trypanosoma cruzi | TcCLB.506211.250 | fibrillarin, putative |
Trypanosoma cruzi | TcCLB.509715.40 | fibrillarin, putative |
Trypanosoma cruzi | TcCLB.511287.150 | fibrillarin, putative |
Toxoplasma gondii | TGME49_311430 | fibrillarin |
Theileria parva | TP04_0795 | fibrillarin, putative |
Trichomonas vaginalis | TVAG_380100 | fibrillarin, putative |
Trichomonas vaginalis | TVAG_282140 | fibrillarin, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.7500 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.7500 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.7500 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.10.7500 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.10.14750 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.14750 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.14750 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.14750 this record | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_T01C3.7 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_T01C3.7 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_T01C3.7 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_T01C3.7 | Caenorhabditis elegans | slow growth | wormbase |
CELE_T01C3.7 | Caenorhabditis elegans | sterile | wormbase |
YDL014W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1035100 | Plasmodium berghei | Essential | plasmo |
TGME49_311430 | Toxoplasma gondii | Probably essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 3 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.